abstract |
The present invention relates to an interleukin-4 receptor binding protein fusion. More particularly, the present invention provides, in part, a fusion protein comprising an interleukin-4 or interleukin-13 protein portion linked to an anti-apoptotic Bcl-2 family member protein portion. |